Ethanol metabolism by gastric alcohol dehydrogenase (ADH) is thought to be an important determinant of peripheral ethanol time-concentration curves (AUCs) in rats and humans. We quantitated this metabolism in rats by measuring the gastric absorption of oral ethanol (0.25 g/kg) and the gastric venousarterial (V-A) difference of ethanol versus ethanol metabolites (acetate, acetaldehyde, and bicarbonate). Over 1 h, -20% of the ethanol was absorbed from the stomach and 70% was emptied into the duodenum. The gastric V-A difference of ethanol metabolites was < 4% of that of ethanol. Thus, gastric metabolism accounted for < 1% (< 4% of 20% absorbed) of the dose. This negligible metabolism was predictable from the low affinity of gastric ADH for ethanol. In contrast, gastric ADH has a high affinity for octanol, and 66% ofthis compound was metabolized during gastric absorption. Evidence supporting gastric metabolism of ethanol largely derives from the lower AUCs observed after oral than after intravenous administration; however, we observed increasingly higher AUCs with increasingly rapid portal vein infusions of identical ethanol doses. We conclude that gastric metabolism of ethanol is negligible in the rat, and differences in AUCs ascribed to gastric metabolism may reflect differences in ethanol absorption. (J. Clin. Invest. 1992.
Introduction
Isozymes of alcohol dehydrogenase (ADH)' are present in the gastric mucosa of humans and rats (1) (2) (3) (4) (5) , and it has been proposed that gastric ADH metabolizes 20-80% of ingested ethanol (6) (7) (8) . Decreased gastric metabolism ofingested ethanol in females compared with males has been offered as an explanation for the increased vulnerability of females to ethanol (9) . Medications such as some H-2 blockers and aspirin are said to inhibit gastric ADH activity, causing higher-than-expected blood ethanol levels (10, 11) . Chronic ethanol exposure is thought to decrease gastric metabolism of ethanol in humans (8, 9) , thus increasing the systemic exposure to this toxin.
The majority ofstudies purporting to document gastric metabolism of ethanol have examined differences in peripheral blood ethanol time-concentration curves after oral versus intravenous administration of ethanol (6) (7) (8) (9) (10) (11) (12) . These studies, initially carried out in rats and then in humans, demonstrated lower peak blood ethanol concentrations and decreased areas under the curve (AUC) with oral administration. Additional evidence cited to support the concept ofgastric metabolism of ethanol is the finding of higher concentrations of ethanol metabolites in portal vein versus arterial blood after gastric instillation of ethanol in pylorus-ligated rats (13, 14) .
The above evidence does not, however, provide a compelling argument in support ofappreciable ethanol metabolism by the gastric mucosa. To metabolize 20-80% of an ingested dose ofethanol, gastric metabolism must approach 100% ofthe ethanol absorbed from the stomach since an appreciable fraction is emptied into the duodenum. However, a sizable fraction ofa comparable quantity of ethanol escapes first-pass metabolism in the liver, although the total hepatic ADH activity is manyfold greater than that ofthe stomach and the Km for ethanol of hepatic ADH is orders of magnitude lower than that of the gastric enzyme (4, 5) . Thus, it would seem unlikely that gastric mucosal ADH could account for 20-80% of the total body metabolism ofethanol. The demonstration offirst-pass metabolism via comparison ofAUCs after oral and intravenous drug administration requires that clearance follow first-order kinetics (15) . However, hepatic ADH is readily saturated by small doses of ethanol, with resultant zero-order removal kinetics (16) . Last, the reported venous-arterial (V-A) differences in ethanol metabolites across the stomach (13, 14) were trivial relative to that of ethanol, a result that argues against, rather than for, appreciable ethanol metabolism by the stomach. Perhaps the best evidence for gastric metabolism of ethanol was the finding that the maintenance of similar blood ethanol levels required a more rapid constant infusion of ethanol when administered intragastrically versus intravenously (7) . However, interpretation ofthis study is complicated by the accumulation ofethanol in the gastrointestinal tract ofthe animals receiving intragastric ethanol.
In this study we first quantitated the gastric mucosal metabolism of an orally administered load of ethanol in the rat by measuring the gastric absorption ofethanol and the fraction of this absorbed ethanol that was metabolized by the stomach. Finding negligible gastric metabolism of ethanol, additional studies were carried out to demonstrate that variations in the gastrointestinal absorption rate of ethanol could readily explain previously observed differences in AUCs.
Methods
All experiments were performed on male Sprague-Dawley rats (weight 290-380 g) allowed free access to standard rat chow and water until the time of the experimental procedure. First-pass gastric metabolism of ethanol. Animals were anesthetized with acepromazine (3 mg/kg) and ketamine (65 mg/kg) via an intraperitoneal injection, the abdomen was opened, and a catheter was passed through the duodenum into the stomach. The duodenum was ligated just distal to the pylorus and the esophagus was ligated at the gastroesophageal junction. Ethanol, 0.25 g/kg, was then instilled as a 2.5% aqueous solution into the stomach of the test animals, whereas the controls received a similar quantity ofwater; and at 5, 10, or 15 min blood (-0.5 ml) was obtained from the left gastric vein using a 27-gauge needle. An To determine the gastric V-A difference of bicarbonate derived from ethanol metabolism, the animals received an intragastric infusion of 0.25 g/kg of [ -'4C]ethanol (2.5 usCi/ml) as a 2.5% (wt/vol) solution in water. Gastric vein and cardiac blood samples were collected and centrifuged anaerobically for 3 min at 12,000g. The serum (0.5 ml) was collected anaerobically and bicarbonate was precipitated by the addition, on ice, of 1 ml of 100 mM unlabeled sodium bicarbonate and 2 ml of 0.3 N Ba(OH)2. After centrifugation for 3 min at 12,000 g, the precipitate was washed with 2 ml of cold 0.3 N Ba(OH)2 and recentrifuged. The precipitated BaCO3 was then solubilized with 1 ml of0.5 M hyamine and added to 10 ml of scintillation cocktail (Ultima Gold; Packard Instrument Co. Inc., Downers Grove, IL) and counted in a liquid scintillation counter. The supernatants from this precipitation procedure and the wash also were counted by adding 100 1Al to 10 ml of Ultima Gold and I ml of 0. To determine whether ethanol or an ethanol metabolite was bound to gastric tissue, the gastric lumen was thoroughly washed, and the stomach was then homogenized in 20 ml of saline. A 25-Ml aliquot of this homogenate was added to 10 ml of Ultima Gold and radioactivity was measured by scintillation counting.
First-pass gastric metabolism ofoctanol. The procedure employed was similar to that described for ethanol, with the exception that the gastric instillate consisted of 2 ml of water containing 0.64 mg and 7.4
MCi of [ _1 4Cloctanol (ICN Biomedicals Inc., Costa Mesa, CA). Gastric vein and cardiac blood samples were obtained at 5 min after instillation of [14Cloctanol in five rats. The serum concentration of ['4C]octanol versus its more polar metabolites was determined as follows. 1 ml of water was added to 0.2 ml of plasma, and this mixture was then extracted three times with 1 ml ofethyl acetate. With the first extraction, it was necessary to centrifuge to obtain good separation of the two phases. The combined ethyl acetate extract was extracted three times with 1 ml of 2 N NaOH. The radioactivity in the aqueous (NaOH) and ethyl acetate phases was then determined by liquid scintillation counting. Studies with authentic octanol and octanoic acid in rat plasma demonstrated that < 0.1% of the octanoic acid was extracted in the ethyl acetate and < 0.5% of the octanol was in the NaOH.
First-pass small bowel metabolism ofethanol. Via a midline incision, a 20-cm loop ofsmall intestine beginningjust beyond the pylorus was isolated between ligatures. Ethanol (0.25 g/kg) was instilled into the intestinal segment. Arterial and portal blood samples collected at 5, 10, and 15 min were analyzed for ethanol, acetate, acetaldehyde, and ['4Cjbicarbonate. Four to six animals were evaluated at each time period.
Portal vein infusion ofethanol. The ileocecal vein of anesthetized rats was cannulated with PE-50 tubing and the tubing was then advanced into the portal vein. Ethanol dissolved in saline was constantly infused into the portal vein at a rate sufficient to deliver a dosage of0.25 g/kg over 5, 15, 30, 60, or 90 min using a syringe infusion pump (model 22; Harvard Apparatus Co. Inc., South Natick, MA). Tail vein blood samples were collected every 10 min for 60 min and then every 30 min for the subsequent 120 min. Three to four animals were studied at each infusion rate.
GCanalysis ofethanol, acetaldehyde, and acetate. For the measurement of ethanol and acetate, blood samples (or gastric contents) were immediately deproteinized with 2 vol ofcold 0.6 N perchloric acid and then centrifuged at 40C for 10 min at 13,000 g ( 18) . Acetate was esterified to methylacetate and quantified by head space GC, essentially as described by Giles et al. (19) . A 0.25-ml aliquot ofprotein-free supernatant or acetate standard was added to a glass GC septum vial containing 0.6 ml ofan aqueous, acidified methanol solution (5 parts concentrated sulfuric acid, 25 parts methanol, and 30 parts water by volume). The samples were heated for 30 min at 550C in the heating block of a gas chromatograph (model Sigma 2000; Perkin-Elmer Corp., Norwalk, CT) equipped with a head space autosampler (model HS-100; PerkinElmer Corp.) and hydrogen flame ionization detectors. The chromatography conditions were as follows: column, 1/8 in x 6 ft stainless steel packed with Porapak QS, 80-100 mesh (Alltech Associates, Inc., Deerfield, IL); column temperature, 130°C; carrier gas, nitrogen; carrier gas flow rate, 40 ml/min. Since methanol interfered with the analysis of ethanol under the above conditions, ethanol was assayed separately. A 0. l-ml aliquot of the protein-free supernatant was added to a GC vial containing 0.75 ml of 0.8 mM n-propanol (internal standard). The samples were heated for 10 min at 55°C in the heating block of the autosampler and ethanol was quantified by head space GC analysis. The following chromatography conditions were used: column, 2 mm (i.d.) X 2 m glass packed with Tenax GC, 80-100 mesh (Alltech Associates, Inc.); column temperature, 1 10°C; carrier gas, nitrogen; carrier gas flow rate, 40 ml/min. In the ethanol clearance studies, tail vein blood ethanol was measured using a modification of a method described by Coldwell et al. (20) . Immediately after collection, 20 ,l of whole blood was expelled onto an azide-treated paper disk (no. 1 filter paper [Whatman Laboratory Products Inc., Clifton, NJ] impregnated with 1 M sodium azide) contained within a GC vial followed by the addition of 4.0 mM n-propanol, internal standard. The chromatographic conditions used were the same as described for ethanol above.
Blood acetaldehyde was measured as previously described (21) . Blood acetaldehyde and acetate values were calculated on the basis of peak areas, whereas blood ethanol values were computed using peak area ratios with n-propanol as the internal standard.
Results
Gastric emptying and gastric absorption of ethanol. Fig. 1 shows the percentages of the gavaged dose ofethanol absorbed from the stomach and emptied into the duodenum at 15, 30, and 60 min. The majority ofethanol absorption from the stomach occurred within the first 15 min. By 60 min, 20% of the ethanol dose had been absorbed across the gastric mucosa and 71% had been emptied into the duodenum.
First-pass gastric metabolism ofethanol. Fig. 2 shows the V-A differences of ethanol and acetate across the stomach. In the control animals that did not receive ethanol, there was no V-A difference for ethanol or acetate. 5 min after the intragastric instillation of ethanol, there was a mean V-A difference of ethanol of 19.0 mM but only a 0.06 mM V-A difference for acetate. At 10 and 15 min the V-A differences for ethanol were 11.7 and 5.18 mM, respectively, with a V-A difference for acetate of 0.06 mM at 10 min and 0.26 mM at 15 min. The V-A difference for acetaldehyde at 5, 10, and 15 min was < 6 uM. Fig. 3 Fig. 4 ). The ratio of octanol metabolites to octanol in gastric vein blood averaged 1.35, with a range of 1.04-1.68.
First-pass small bowel metabolism ofethanol. (6, 7, 12) and humans (8, 9, 22 (8) .
The percentage of an oral dose of ethanol that undergoes first-pass metabolism in the stomach is determined by the fraction of the dose absorbed from the stomach and the efficiency with which this absorbed ethanol is metabolized by the gastric mucosa. In the present study, we quantitatively assessed these two factors after the oral administration of a small dose of ethanol (0.25 g/kg) to fed male rats, the experimental conditions reported to maximize gastric metabolism of ethanol (6) .
At 60 min, 91% of the dose had left the stomach, of which 20% had been absorbed across the gastric mucosa and 71% had emptied into the duodenum. Thus, roughly 20% of the original dose was the maximum percentage of ethanol available for gastric metabolism; and virtually 100% of this ethanol would have to undergo first-pass metabolism if the stomach is to account for just 20% of the total metabolism.
The percentage of the ethanol metabolized during absorption from the stomach was determined by comparing the gastric V-A difference for ethanol with that ofits metabolites (acetaldehyde, acetate, and bicarbonate). The gastric V-A differences for acetaldehyde and acetate across the rat gastric mucosa were < 1% of the V-A difference for ethanol indicating, that < 1% of the ethanol absorbed from the stomach was metabo- Less than 3% of the ethanol absorbed from the stomach was oxidized to 14CO2. Thus, we concluded that < 4% of the ethanol absorbed from the stomach was metabolized to acetaldehyde, acetate, or CO2. Because only 20% of the original dose was absorbed across the rat gastric mucosa, gastric metabolism was responsible for < 1% ofthe total dose ofethanol. Measurements of V-A differences across the upper small intestine also indicated that there was negligible first-pass metabolism ofethanol in the small bowel.
The inability to demonstrate appreciable gastric metabolism ofethanol in the stomach ofthe rat was not entirely unexpected, given the content and kinetic characteristics of the ADH present in rat gastric mucosa. Julia et al. (4, 5) showed that ethanol is a very poor substrate for the ADH found in rat gastric mucosa, with a reported Km ranging from 3,000 to 5,000 mM at pH 7.5.
On the basis of in vitro measurements of the total ADH activity in the rat stomach (4), if the gastric mucosa were exposed to the roughly 500-mM ethanol concentration instilled into the stomach in our experiments, only -0.4% of the dose would be metabolized in 1 h. In reality, the ethanol concentration in the mucosa would be only a small fraction of the luminal concentration because a thick unstirred water layer of -900 .um separates luminal contents from the gastric mucosa ofthe rat (24) . Since the gastric mucosal cell is in close approximation to the capillaries, and since the cell and capillary membranes are very permeable to ethanol, the ethanol concentration in the mucosa should be much closer to that of gastric venous blood (peak of -20 mM) than that in the lumen. With a mucosal concentration of 20 mM, < 0.04% of the ethanol dose would be expected to be metabolized by the gastric mucosa in 1 h. Although prediction ofin vivo metabolism from in vitro measurements often is far from perfect, gastric mucosal metabolism ofethanol would become appreciable only ifthe in vitro kinetic parameters underestimated in vivo values for ADH by several orders of magnitude.
In contrast to the situation with ethanol, gastric ADH has a high affinity for octanol, with a reported Km of 0.5 mM (5). Using measurements of V-A difference, we found that -66% of [14C]octanol absorbed from the stomach was metabolized during passage across the gastric mucosa. This finding demonstrates that gastric ADH can metabolize low concentrations of a substrate for which it has a high affinity and that this metabolism is readily detected using the V-A difference technique.
Although the finding of lower AUCs with oral than with intravenous ethanol administration repeatedly has been used as evidence offirst-pass gastric metabolism ofethanol, this conclusion is valid only when the overall metabolic clearance follows first-order kinetics. If there is saturation of the clearance mechanism, as is the case with ethanol (14) Meaningful comparison ofAUCs obtained with oral versus intravenous administration ofethanol requires a similar rate of ethanol delivery to the liver. In most reports ethanol delivery was far more rapid with the intravenous infusion; therefore, a greater AUC would be expected with intravenous than with oral administration and gastric metabolism need not be implicated. The finding that oral and intravenous administration of ethanol yields similar AUCs in fasted animals or animals receiving high doses of ethanol has been attributed to reduced gastric metabolism resulting, respectively, from rapid gastric emptying or saturation ofgastric ADH. An alternative explanation is that rapid gastric emptying and high doses of ethanol both yield a rapid hepatic delivery of ethanol that exceeds the V,, of clearance. As a result, the quantity of ethanol reaching the systemic circulation with the oral dosing is comparable to that of the intravenous infusion.
We conclude that there is negligible first-pass metabolism of ethanol in the rat stomach. Although the possibility cannot be excluded that such metabolism occurs in the human stomach, the impetus to look for first-pass gastric metabolism in humans was observations made in the rat. The percentage of ethanol metabolism purported to occur via first-pass gastric metabolism in humans is roughly of the same order as in the rat, and the same AUC technique used in rats is the major evidence for first-pass metabolism in humans. Last, although human gastric mucosal ADH has a lower Km for ethanol than does the rat enzyme, in vitro measurements of human gastric ADH activity are relatively unimpressive. For example, a recent paper reported that the rate of ethanol oxidation by human gastric mucosal ADH at pH 7.5 and an ethanol concentration of 50 mM was -2 nmol NADH/min per mg of cytosolic protein (25) . Assuming a total gastric mucosal cytosolic protein of roughly 20 g (10% of 200 g of mucosa), this ADH activity would oxidize only -2 mmol or -0.4% of the administered dose of ethanol in 1 h.
On the basis of our finding of negligible gastric ethanol metabolism in the rat and the lack ofevidence for this phenomenon in humans, we believe that the concept of appreciable Gastric Ethanol Metabolism 1805 first-pass gastric metabolism of ethanol should be considered speculative until direct supporting evidence is presented.
